Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE38.0300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots36.3000/ 20
- Ask / Lots38.2000/ 1
- Open / Previous Close38.5800 / 38.0300
- Day Range
- 52 Week Range
- Volume1,227,343
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 15780 | 38.54 |
| 09:33 ET | 100 | 38.56 |
| 09:35 ET | 530 | 38.76 |
| 09:42 ET | 3888 | 38.81 |
| 09:46 ET | 1077 | 38.76 |
| 09:48 ET | 1354 | 38.81 |
| 09:50 ET | 1000 | 38.79 |
| 09:51 ET | 8167 | 38.75 |
| 09:53 ET | 1800 | 38.79 |
| 09:55 ET | 3467 | 38.77 |
| 09:57 ET | 1251 | 38.785 |
| 10:00 ET | 4933 | 38.75 |
| 10:02 ET | 1900 | 38.75 |
| 10:04 ET | 37984 | 38.71 |
| 10:06 ET | 1116 | 38.76 |
| 10:08 ET | 300 | 38.775 |
| 10:09 ET | 737 | 38.86 |
| 10:11 ET | 419 | 38.84 |
| 10:13 ET | 700 | 38.62 |
| 10:15 ET | 1000 | 38.695 |
| 10:18 ET | 2860 | 38.65 |
| 10:20 ET | 1644 | 38.58 |
| 10:22 ET | 961 | 38.63 |
| 10:24 ET | 2636 | 38.55 |
| 10:26 ET | 5006 | 38.43 |
| 10:27 ET | 2768 | 38.35 |
| 10:29 ET | 945 | 38.35 |
| 10:31 ET | 1500 | 38.345 |
| 10:33 ET | 1300 | 38.45 |
| 10:36 ET | 1860 | 38.35 |
| 10:38 ET | 3428 | 38.265 |
| 10:40 ET | 8663 | 38.275 |
| 10:42 ET | 2300 | 38.305 |
| 10:44 ET | 700 | 38.38 |
| 10:45 ET | 1372 | 38.43 |
| 10:49 ET | 2044 | 38.36 |
| 10:51 ET | 600 | 38.33 |
| 10:54 ET | 800 | 38.33 |
| 10:56 ET | 935 | 38.25 |
| 10:58 ET | 300 | 38.28 |
| 11:00 ET | 4774 | 38.25 |
| 11:02 ET | 3532 | 38.28 |
| 11:03 ET | 4400 | 38.3 |
| 11:05 ET | 414 | 38.29 |
| 11:07 ET | 2750 | 38.245 |
| 11:09 ET | 19661 | 38.23 |
| 11:12 ET | 7903 | 38.26 |
| 11:14 ET | 5864 | 38.245 |
| 11:16 ET | 5075 | 38.245 |
| 11:18 ET | 9992 | 38.25 |
| 11:20 ET | 758 | 38.26 |
| 11:21 ET | 400 | 38.265 |
| 11:23 ET | 400 | 38.245 |
| 11:25 ET | 2200 | 38.1261 |
| 11:27 ET | 1403 | 38.2 |
| 11:30 ET | 100 | 38.195 |
| 11:34 ET | 700 | 38.26 |
| 11:36 ET | 100 | 38.24 |
| 11:38 ET | 100 | 38.23 |
| 11:39 ET | 1000 | 38.265 |
| 11:41 ET | 1877 | 38.2 |
| 11:43 ET | 900 | 38.2 |
| 11:45 ET | 2002 | 38.25 |
| 11:48 ET | 1646 | 38.25 |
| 11:50 ET | 644 | 38.25 |
| 11:52 ET | 1492 | 38.29 |
| 11:54 ET | 600 | 38.25 |
| 11:56 ET | 700 | 38.2516 |
| 11:57 ET | 1600 | 38.29 |
| 11:59 ET | 500 | 38.26 |
| 12:01 ET | 900 | 38.3 |
| 12:03 ET | 1100 | 38.26 |
| 12:06 ET | 200 | 38.26 |
| 12:08 ET | 15852 | 38.26 |
| 12:10 ET | 1100 | 38.31 |
| 12:12 ET | 1000 | 38.31 |
| 12:14 ET | 902 | 38.3 |
| 12:15 ET | 1547 | 38.25 |
| 12:17 ET | 4005 | 38.26 |
| 12:19 ET | 900 | 38.28 |
| 12:21 ET | 2112 | 38.26 |
| 12:24 ET | 1100 | 38.33 |
| 12:26 ET | 200 | 38.29 |
| 12:28 ET | 826 | 38.29 |
| 12:30 ET | 200 | 38.315 |
| 12:32 ET | 200 | 38.31 |
| 12:33 ET | 1045 | 38.2622 |
| 12:35 ET | 700 | 38.25 |
| 12:37 ET | 1100 | 38.25 |
| 12:39 ET | 6675 | 38.26 |
| 12:42 ET | 3867 | 38.295 |
| 12:44 ET | 500 | 38.285 |
| 12:46 ET | 1125 | 38.34 |
| 12:48 ET | 400 | 38.32 |
| 12:50 ET | 900 | 38.33 |
| 12:51 ET | 300 | 38.3 |
| 12:53 ET | 1762 | 38.35 |
| 12:55 ET | 100 | 38.32 |
| 12:57 ET | 700 | 38.3 |
| 01:00 ET | 700 | 38.29 |
| 01:02 ET | 500 | 38.29 |
| 01:04 ET | 538 | 38.29 |
| 01:06 ET | 1161 | 38.28 |
| 01:08 ET | 1600 | 38.25 |
| 01:09 ET | 4201 | 38.25 |
| 01:11 ET | 3645 | 38.25 |
| 01:13 ET | 1550 | 38.25 |
| 01:15 ET | 10776 | 38.13 |
| 01:18 ET | 3285 | 38.205 |
| 01:20 ET | 1881 | 38.11 |
| 01:22 ET | 2239 | 38.02 |
| 01:24 ET | 5629 | 38.03 |
| 01:26 ET | 648 | 38.02 |
| 01:27 ET | 3455 | 38.04 |
| 01:29 ET | 1100 | 38.08 |
| 01:31 ET | 898 | 38.065 |
| 01:33 ET | 2043 | 38.06 |
| 01:36 ET | 1500 | 38.03 |
| 01:38 ET | 1000 | 38.02 |
| 01:40 ET | 3923 | 38.035 |
| 01:42 ET | 2600 | 38.06 |
| 01:44 ET | 3200 | 38.05 |
| 01:45 ET | 1200 | 38.05 |
| 01:47 ET | 1600 | 38.05 |
| 01:49 ET | 1480 | 38.05 |
| 01:51 ET | 2342 | 38.05 |
| 01:54 ET | 200 | 38.05 |
| 01:56 ET | 2542 | 38.03 |
| 01:58 ET | 4834 | 38.045 |
| 02:00 ET | 600 | 38.06 |
| 02:02 ET | 720 | 38.04 |
| 02:03 ET | 2035 | 38.03 |
| 02:05 ET | 1200 | 38.08 |
| 02:07 ET | 1407 | 38.09 |
| 02:09 ET | 300 | 38.13 |
| 02:12 ET | 828 | 38.1 |
| 02:14 ET | 808 | 38.13 |
| 02:16 ET | 2146 | 38.09 |
| 02:18 ET | 1527 | 38.14 |
| 02:20 ET | 1014 | 38.14 |
| 02:21 ET | 200 | 38.14 |
| 02:23 ET | 1200 | 38.115 |
| 02:25 ET | 1357 | 38.11 |
| 02:27 ET | 1100 | 38.095 |
| 02:30 ET | 1490 | 38.02 |
| 02:32 ET | 1936 | 38.02 |
| 02:34 ET | 2642 | 38.045 |
| 02:36 ET | 600 | 38.09 |
| 02:38 ET | 1800 | 38.07 |
| 02:39 ET | 963 | 38.085 |
| 02:41 ET | 400 | 38.08 |
| 02:45 ET | 1979 | 38.055 |
| 02:48 ET | 900 | 38.04 |
| 02:50 ET | 700 | 38.045 |
| 02:52 ET | 2201 | 38.03 |
| 02:54 ET | 1115 | 38.07 |
| 02:56 ET | 600 | 38.06 |
| 02:57 ET | 200 | 38.07 |
| 02:59 ET | 1866 | 38.07 |
| 03:01 ET | 2200 | 38.075 |
| 03:03 ET | 3030 | 38.03 |
| 03:06 ET | 900 | 38.055 |
| 03:08 ET | 2163 | 38.005 |
| 03:10 ET | 3467 | 38 |
| 03:12 ET | 5314 | 38.02 |
| 03:14 ET | 3095 | 38.01 |
| 03:15 ET | 2021 | 38 |
| 03:17 ET | 2670 | 38.005 |
| 03:19 ET | 3354 | 38 |
| 03:21 ET | 6656 | 38 |
| 03:24 ET | 10704 | 38.02 |
| 03:26 ET | 3142 | 38.1 |
| 03:28 ET | 2000 | 38.01 |
| 03:30 ET | 3856 | 38.045 |
| 03:32 ET | 2059 | 38.05 |
| 03:33 ET | 2829 | 38.03 |
| 03:35 ET | 5153 | 38.02 |
| 03:37 ET | 1500 | 38.01 |
| 03:39 ET | 6463 | 38.03 |
| 03:42 ET | 3052 | 38.01 |
| 03:44 ET | 3750 | 38.02 |
| 03:46 ET | 3746 | 38.05 |
| 03:48 ET | 3263 | 38.0527 |
| 03:50 ET | 4131 | 38.035 |
| 03:51 ET | 8835 | 38.07 |
| 03:53 ET | 8223 | 38.06 |
| 03:55 ET | 19228 | 38 |
| 03:57 ET | 21254 | 38.01 |
| 04:00 ET | 245764 | 38.03 |
Dec 5, 2022
Ionis Pharmaceuticals Says European Medicines Agency Accepts Application to Review Experimental ALS Drug, from 9:41AM ET on Monday Dec 05, 2022 by MT Newswires
9:41AM ET on Monday Dec 05, 2022 by MT NewswiresBRIEF-Ionis Says EMA Accepts Marketing Authorization Application Of Tofersen, from 8:02AM ET on Monday Dec 05, 2022 by Thomson Reuters
8:02AM ET on Monday Dec 05, 2022 by Thomson ReutersIonis announces European Medicines Agency accepts Marketing Authorization Application of tofersen to treat rare, genetic form of ALS, from 7:30AM ET on Monday Dec 05, 2022 by PR Newswire
7:30AM ET on Monday Dec 05, 2022 by PR Newswire
Nov 14, 2022
BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, AMC, AMD, from 1:52PM ET on Monday Nov 14, 2022 by Thomson Reuters
1:52PM ET on Monday Nov 14, 2022 by Thomson ReutersIonis Pharmaceuticals, Metagenomi Sign Collaboration Deal To Produce Investigational Medicines, from 6:34AM ET on Monday Nov 14, 2022 by MT Newswires
6:34AM ET on Monday Nov 14, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 5.5B | 656.7x | --- |
CRISPR Therapeutics AG | 4.1B | -5.8x | --- |
Guardant Health Inc | 5.3B | -8.3x | --- |
Azenta Inc | 4.5B | -389.3x | --- |
Medpace Holdings Inc | 6.4B | 31.3x | +67.16% |
Maravai LifeSciences Holdings Inc | 3.4B | 5.3x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily focused on our cardiovascular and neurology franchises. Its products include SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA is for the treatment of patients of all ages with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. TEGSEDI is for the treatment of patients with polyneuropathy caused by hereditary transthyretin (TTR), amyloidosis (hATTR), a debilitating, progressive, and fatal disease. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients. The Company has over six medicines in Phase III studies for eight indications, which include Eplontersen (TTR), Olezarsen (ApoC-III), Donidalorsen (PKK), ION363 (FUS), Pelacarsen (Apo(a)) and Tofersen (SOD1). Its cardiovascular medicine in development includes Eplontersen, Olezarsen, Pelacarsen, ION449 (PCSK9), Fesomersen and IONIS-AGT-LRx.
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.4B |
|---|---|
Revenue (TTM) | $875.5M |
Shares Outstanding | 142.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.54 |
EPS | $0.06 |
Book Value | $5.47 |
P/E Ratio | 656.7x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | 217.3x |
Operating Margin | 2.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
